ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Feb 19, 2015
Insider Transaction Report
Form 4
Hacksell Uli
DirectorCEO
Transactions
- Gift
Common Stock
2015-02-17−30,000→ 0 total - Exercise/Conversion
Common Stock
2015-02-17$1.55/sh+30,000$46,500→ 30,000 total - Gift
Common Stock
2015-02-17+30,000→ 145,549 total(indirect: By Trust) - Sale
Common Stock
2015-02-17$34.30/sh−30,000$1,028,868→ 115,549 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2015-02-17−30,000→ 313,500 totalExercise: $1.55Exp: 2020-03-11→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2014.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $34.52 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]25% of the shares subject to the stock option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.